Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Telaprevir”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00933283
What this trial is testing

Investigate the Potential Interaction Between Telaprevir and Methadone, at Steady-State

Who this might be right for
Healthy Participants
Tibotec BVBA 18
Post-approval studies (Phase 4)Study completedNCT02087111
What this trial is testing

Telaprevir in Genotype 3 HCV

Who this might be right for
Hepatitis C
Queen Mary University of London 14
Not applicableStudy completedNCT01514890
What this trial is testing

French Cohort of Therapeutic Failure and Resistances in Patients Treated With a Protease Inhibitor (Telaprevir or Boceprevir), Pegylated Interferon and Ribavirin

Who this might be right for
Chronic Hepatitis C
ANRS, Emerging Infectious Diseases 675
Testing effectiveness (Phase 2)Ended earlyNCT01080222
What this trial is testing

A Safety and Efficacy Study of the Combination of VX-222 and Telaprevir in Treatment-Naïve Subjects With Genotype 1 Chronic Hepatitis C Virus Infection

Who this might be right for
Chronic Hepatitis C Virus Infection
Vertex Pharmaceuticals Incorporated 152
Large-scale testing (Phase 3)Study completedNCT01241760
What this trial is testing

VX-950-C211 - A Dosing Regimen Study (Twice Daily Versus Every 8 Hours) of Telaprevir in Treatment-naïve Participants With Genotype 1 Chronic Hepatitis C Virus Infection

Who this might be right for
Genotype 1 Chronic Hepatitis CTreatment Naive
Janssen Infectious Diseases BVBA 744
Early research (Phase 1)Study completedNCT01563328
What this trial is testing

Evaluate the Effect of Boceprevir and Telaprevir on Dolutegravir Pharmacokinetics in Healthy Adult Subjects (ING115697).

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 32
Not applicableStudy completedNCT01641094
What this trial is testing

Effect of Teleprevir in Triple Therapy on Intrahepatic Immunological Mechanisms

Who this might be right for
Chronic Hepatitis C
Foundation for Liver Research 20
Large-scale testing (Phase 3)Study completedNCT00758043
What this trial is testing

A Study Evaluating 24-Week and 48-Week Telaprevir-Based Regimen in Treatment Naïve Subjects With Genotype 1 Chronic Hepatitis C Who Achieve an Extended Rapid Viral Response

Who this might be right for
Hepatitis C
Vertex Pharmaceuticals Incorporated 540
Post-approval studies (Phase 4)Ended earlyNCT01467492
What this trial is testing

Telaprevir, Peg-IFN-alfa-2a, and RBV in Treatment-Experienced Black/African American and Non-Black/African American Subjects With Genotype 1 Chronic Hepatitis C

Who this might be right for
Hepatitis C
Vertex Pharmaceuticals Incorporated 121
Not applicableStudy completedNCT02113631
What this trial is testing

Comparative Effectiveness and Tolerability of Boceprevir vs Telaprevir

Who this might be right for
Hepatitis C, ChronicCirrhosis
Louis Stokes VA Medical Center 50
Early research (Phase 1)Study completedNCT01511432
What this trial is testing

Assess the Relative Bioavailability Three New Formulations of Telaprevir in Healthy Subjects

Who this might be right for
Chronic Hepatitis C
Vertex Pharmaceuticals Incorporated 64
Early research (Phase 1)Study completedNCT01818856
What this trial is testing

Pharmacokinetic Interactions Between Telaprevir and Un-boosted Atazanavir

Who this might be right for
Hepatitis C, ChronicHIV Infection
Hospitales Universitarios Virgen del Rocío 14
Early research (Phase 1)Study completedNCT00973388
What this trial is testing

VX-950-TiDP24-C136 - A Trial to Evaluate the Effect of Telaprevir (TVR) on the Results of Electrocardiograms (Electric Recording of the Heart) in Healthy Volunteers

Who this might be right for
Hepatitis C
Tibotec BVBA 44
Early research (Phase 1)Study completedNCT01336829
What this trial is testing

TMC125IFD1001 - Drug-Drug Interaction of Etravirine With Telaprevir and TMC278 With Telaprevir.

Who this might be right for
Hepatitis CHIV
Tibotec Pharmaceuticals, Ireland 33
Early research (Phase 1)Study completedNCT00775125
What this trial is testing

VX-950-TiDP24-C124: A Phase I Trial to Investigate the Potential Pharmacokinetic Interactions Between Telaprevir and Darunavir/Ritonavir and Between Telaprevir and Fosamprenavir/Ritonavir at Steady-state.

Who this might be right for
Hepatitis CTelaprevirHIV
Tibotec BVBA 40
Testing effectiveness (Phase 2)Study completedNCT01482390
What this trial is testing

Mericitabine in Combination With Telaprevir and Peginterferon Alfa-2a / Ribavirin in Participants With Chronic Hepatitis C

Who this might be right for
Hepatitis C
Hoffmann-La Roche 80
Not applicableStudy completedNCT01980290
What this trial is testing

Telaprevir With Peginterferon Alfa & Ribavirin in Ex-People Who INject Drugs Infected by Genotype 1 Chronic Hepatitis C

Who this might be right for
Hepatitis, Chronic
Janssen Pharmaceutica N.V., Belgium 50
Testing effectiveness (Phase 2)Study completedNCT00892697
What this trial is testing

Intrahepatic HCV RNA and Telaprevir Kinetics in Hepatitis C Virus (HCV)

Who this might be right for
Hepatitis C
Weill Medical College of Cornell University 15
Large-scale testing (Phase 3)Ended earlyNCT01467479
What this trial is testing

Treat Subjects With Telaprevir, Ribavirin, and Peginterferon Who Are Coinfected With HIV and Hepatitis C Virus (HCV)

Who this might be right for
Hepatitis C
Vertex Pharmaceuticals Incorporated 185
Early research (Phase 1)Study completedNCT00509210
What this trial is testing

Study of Telaprevir in Subjects With Hepatic Impairment

Who this might be right for
Hepatic Insufficiency
Vertex Pharmaceuticals Incorporated
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation